Check out our most popular compounded medications! Get Started
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded troche containing gabapentin, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing gabapentin are listed in capsule, tablet, solution and suspension forms. No gabapentin product of any kind is listed in troche form.
Bases for this dose form differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Gabapentin is an anticonvulsant and nerve pain medication, commonly compounded in topical creams and gels and in oral liquids.
Gabapentin is an anticonvulsant that is structurally similar to the neurotransmitter GABA but does not act on GABA receptors. It binds the alpha-2-delta subunit of voltage-gated calcium channels in nerve tissue, which reduces the release of excitatory signaling chemicals. Manufactured products include Neurontin capsules, tablets and oral solution, FDA-approved for postherpetic neuralgia in adults and as add-on therapy for partial onset seizures, and Horizant (gabapentin enacarbil) extended-release tablets, FDA-approved for moderate-to-severe primary restless legs syndrome and for postherpetic neuralgia in adults.
A prescriber may order gabapentin compounded when a patient needs a dosage form that is not manufactured, such as a topical preparation, a strength or liquid concentration that differs from the commercial options, a vehicle free of a specific dye or allergen, or a combination with other active ingredients. Compounded gabapentin preparations are not FDA-approved and require a prescription.
The Neurontin label carries no boxed warning, but it warns of serious, life-threatening or fatal respiratory depression when gabapentin is combined with opioids or other central nervous system depressants, including alcohol. Other label warnings include a severe multi-organ hypersensitivity reaction (DRESS), anaphylaxis and angioedema, increased risk of suicidal thoughts or behavior, and withdrawal symptoms or increased seizures if stopped abruptly. Gabapentin can cause drowsiness and dizziness, so do not drive until you know how it affects you. Do not use it if you are hypersensitive to it. Aluminum or magnesium antacids reduce absorption of oral gabapentin, and morphine can raise gabapentin levels. Tell your prescriber or pharmacist if you have kidney disease or breathing problems. The label states gabapentin passes into breast milk; LactMed reports low infant serum levels and advises watching the infant for drowsiness and weight gain. If you have a rash, swelling, trouble breathing, mood changes or extreme sleepiness, contact your prescriber or pharmacist promptly.
Gabapentin is a GABA analog that does not bind GABA receptors. It binds with high affinity to the alpha-2-delta-1 subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release. Oral bioavailability is not dose proportional and falls as the dose rises. Gabapentin is less than 3 percent protein bound, not appreciably metabolized, does not inhibit the major CYP isoforms at clinically relevant concentrations in vitro and does not interfere with the metabolism of commonly coadministered antiepileptic drugs, and is eliminated unchanged by the kidney with a half-life of 5 to 7 hours; renal impairment prolongs exposure, and dosing is adjusted to creatinine clearance per prescriber. Systemic absorption from topical application is not characterized in the manufactured labeling.
Labeled indications: Neurontin for postherpetic neuralgia in adults and adjunctive therapy of partial onset seizures in patients 3 years and older; Horizant (gabapentin enacarbil) for moderate-to-severe primary restless legs syndrome and postherpetic neuralgia in adults. Prescribers have ordered gabapentin off label for painful diabetic neuropathy, fibromyalgia, hot flashes, pruritus, alcohol withdrawal and refractory chronic cough (StatPearls, MedlinePlus). Dosing, titration and taper are per prescriber; the label advises tapering over at least one week. Monitor renal function, mood and suicidality, sedation, and respiratory status with opioid co-prescription. Gabapentin is not federally controlled but is controlled in some states and reported to prescription monitoring programs in others; verify requirements for the patient's state.
Wash and dry your hands. Place the troche between your cheek and gum or under your tongue, as your label directs, and let it dissolve. Do not chew or swallow it whole unless told to. Dissolving can take up to 30 minutes. Follow your label about eating or drinking around the dose.
Troches are nonaqueous, so a USP <795> default beyond-use date of up to 180 days usually applies. Store in the closed container in a cool, dry place at room temperature, away from heat so they do not soften, and out of reach of children. Discard after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve
